Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
CMY | Ann: Removal from Official List | 19/02/25 | 99 | 87K | |||
|
|||||||
CMY | Listing | 11/07/19 | 1 | 4.2K | |||
|
|||||||
CMY | CHP to 'Voluntarily' Delist from the ASX | 24/02/19 | 0 | 1.5K | |||
|
|||||||
CMY | News: CMY Capital Mining Removed From Official List Of ASX Effective From Close Of Trading On Dec 7 | 07/12/18 | 0 | 1.9K | |||
|
|||||||
CMY | Ann: Cannabis Update | 07/12/18 | 106 | 47K | |||
|
|||||||
CMY | Scenarios for discussion | 23/11/18 | 23 | 17K | |||
|
|||||||
CMY | Ann: Restructure Continues With New Board | 16/10/18 | 14 | 14K | |||
|
|||||||
CMY | News: CMY Capital Mining Expects Ongoing Restructure To Take Minimum Of 90 Days | 17/09/18 | 0 | 2.3K | |||
|
See All Discussions